Search
Find Drugs
Advanced Search

 


Search Result For "targeted cancer therapy"
Brand No available data!
Generic No available data

Votrient 復治恩
Generic Name : Pazopanib
Indication : 1st-line treatment of advanced renal cell carcinoma in adults & for patients who received prior cytokine therapy for advanced disease. Treatment of selective subtypes of advanced soft tissue sarco...
Manufacturer : Novartis
Distributor : DKSH / Four Star

Welireg
Generic Name : belzutifan
Indication : Von Hippel-Lindau disease in adults who require therapy for associated renal cell carcinoma, CNS hemangioblastomas, or pancreatic neuroendocrine tumors, not requiring immediate surgery.
Manufacturer : MSD
Distributor : Zuellig

Xalkori

Xospata
Generic Name : Gilteritinib
Indication : Monotherapy for the treatment of adult patients who have relapsed or refractory AML w/ FMS-like tyrosine kinase 3 (FLT3) mutation.
Manufacturer : Astellas

Zaltrap
Generic Name : Aflibercept
Indication : In combination w/ irinotecan/5-fluorouracil/folinic acid (FOLFIRI) chemotherapy for adults w/ metastatic colorectal cancer that is resistant to or has progressed after an oxaliplatin-containing regime...
Manufacturer : Sanofi

Zelboraf

Zevalin

Zykadia 立克敵
Generic Name : Ceritinib
Indication : Anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC).
Manufacturer : Novartis
Distributor : Four Star / Zuellig

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

No search result found for "targeted cancer therapy"
Some things you can do
  • Check for spelling mistake.
  • Try searching in Find Drug Company.
  • Try browsing by MIMS Class.
  • Try different keywords.
  • Try more general keywords.
  • Try fewer keywords.
Go to Advanced Search

Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in